Amesite Inc.

NASDAQ:AMST
Annual Meeting

of Shareholders

MEETING DATE

12/10/2026
DEF 14A FILED
10/14/2026
PUBLISHED
10/14/2026 8:10 pm
TIME TO PUBLISH
10/16/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:AMST · CUSIP · CLASS common stock · CIK 0001807166

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

5
FOR
1
AGAINST
0
WITHHOLD
6
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of two Class III Directors
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The board nominated Gilbert S. Omenn, M.D., Ph.D. and George Parmer for re-election.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of the appointment of Novogradac & Company LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2027
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The audit committee approved the appointment of Novogradac as independent registered public accounting firm.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approval of an amendment to the Company’s Certificate of Incorporation, at the discretion of the Board, to effect a reverse stock split with respect to the Company’s issued and outstanding common stock, at a ratio of 1-for-2 to 1-for-250, with the ratio to be determined at the discretion of the Board, and to effect the reverse stock split within one year after the date of approval
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the primary reason is to comply with Nasdaq listing requirements.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Approval, for purposes of Nasdaq Listing Rule 5635(d), of the issuance of securities in one or more non-public offerings where such issuance exceeds 19.99% of outstanding shares at less than the Nasdaq minimum price, within one year after the date of approval, subject to certain limitations, for aggregate proceeds of up to $25 million
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

The filing states the issuance could dilute ownership and have an anti-takeover effect.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
Approval, on an advisory basis, of the compensation of the Company’s named executive officers
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the board and Compensation Committee will consider the advisory vote outcome.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
Advisory vote on the frequency of future advisory votes on the compensation of the Company’s named executive officers
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The board recommends holding future advisory votes on executive compensation every year.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

f0b89261fa9017401e57f5f00587aabebb572807ee29bdb9a3811a9a4691a317

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates